Phenotype measures set

ID, description, units MPD:25016   bone mineral content (BMC)   [g]
Measures • 6mo    • 12mo    • 20mo
Data set, strains Ackert1   inbred   31 strains     sex: both
Procedure DXA
Comparisonaging-study, multiple cohorts
Ontology mappings



Dimensions Width:  ×  Height: px
Values
Graph Type
Plot Options
Download Plot   

Ackert1 - bone mineral content (BMC)

Female

Male



  RM-ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
age 2 0.4163 0.2082 86.0066 < 0.0001
sex 1 0.0215 0.0215 8.8905 0.0029
strain 25 9.6823 0.3873 160.0146 < 0.0001
age:sex 2 0.0039 0.002 0.8156 0.4427
age:strain 50 0.6968 0.0139 5.758 < 0.0001
sex:strain 25 1.012 0.0405 16.7251 < 0.0001
age:sex:strain 50 0.3175 0.0063 2.6233 < 0.0001
Residuals 916 2.2171 0.0024

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelNo.
strains
SexAge
Ackert1 25016 DXA (none) bone mineral content (BMC)   [g]   at age 6mo   BMC_M06 inbred 31 both 26wks
Ackert1 25017 DXA (none) bone mineral content (BMC)   [g]   at age 12mo   BMC_M12 inbred 31 both 52wks
Ackert1 25018 DXA (none) bone mineral content (BMC)   [g]   at age 20mo   BMC_M20 inbred 31 both 87wks